ArticleOncoimmunology2016

Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.

María V Martínez-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.